New advances in pancreatic cancer treatment

Written by: Mr Charles Imber
Edited by: Carlota Pano

Pancreatic cancer is a cancer that starts in the pancreas, the organ involved in digestion and hormone secretion. In the UK, more than 10,500 people are diagnosed with pancreatic cancer each year.


Here, renowned consultant general surgeon Mr Charles Imber provides an expert insight into pancreatic cancer. The London-based specialist discusses symptoms, diagnosis, advances in treatment, and more.



What are the early signs and symptoms of pancreatic cancer?


Early signs and symptoms of pancreatic cancer can be vague and easily mistaken for other conditions. However, they may include:


It is important to note that these symptoms can be caused by non-cancerous conditions as well, so a proper medical evaluation is necessary for an accurate diagnosis.


How is pancreatic cancer diagnosed, and what tests are commonly used?


Pancreatic cancer is typically diagnosed through a combination of medical history review, physical examination, and various tests.


Commonly used diagnostic tests for pancreatic cancer include:

  • Imaging tests: These include CT scans, MRI scans, ultrasound, and sometimes PET scans. These tests can help visualise the pancreas and detect any abnormalities or tumours.
  • Biopsy: A biopsy involves taking a tissue sample from the pancreas for examination under a microscope. This can be done through a fine-needle aspiration or surgical biopsy. It is not always necessary to confirm the diagnosis with a biopsy prior to surgery, and I often operate without a tissue diagnosis if the imaging is typical so as not to delay treatment.
  • Blood tests: Certain blood tests can help evaluate pancreatic function and identify specific tumour markers associated with pancreatic cancer, for example CA 19-9


What are the treatment options for pancreatic cancer?


The treatment options for pancreatic cancer depend on several factors, including the stage and location of the cancer, and the overall health of the patient. Treatment approaches may include:

  • Surgery: If the cancer is localised and has not spread, surgery to remove the tumour (a pancreaticoduodenectomy or a distal pancreatectomy) may be an option. More and more, I am able to offer minimally invasive surgical techniques, including laparoscopic and robotic surgery.
  • Radiation therapy: This treatment uses high-energy X-rays or other particles to destroy cancer cells or reduce tumour size. Radiation therapy can be used before surgery (neoadjuvant), after surgery (adjuvant), or for palliative purposes. I am able to offer high-dose MR-Linac therapy, which is a very accurately-targeted, high-dose treatment.
  • Chemotherapy: This treatment uses drugs to kill cancer cells or to inhibit their growth. Chemotherapy may be used before or after surgery, or in cases where surgery is not possible. I am now able to downstage a locally advanced cancer involving major blood vessels with a combination of chemo-radiotherapy prior to an operation (neo-adjuvant treatment). This has an added bonus of selecting out the patients that benefit most with surgical treatment.
  • Targeted therapy: These medications target specific abnormalities or genetic mutations in cancer cells to disrupt their growth and survival.


What are the survival rates for pancreatic cancer?


Pancreatic cancer has a relatively low survival rate compared to other cancers. However, survival rates can vary depending on the stage of cancer at diagnosis and the patient's overall health.


According to the American Cancer Society, the overall five-year survival rate for pancreatic cancer is around 10 per cent. However, it is important to note that survival rates are statistical averages, and individual cases may vary. With newer approaches to treatment, a greater proportion of patients are achieving successful surgical resection.


Are there any new advancements or emerging treatments for pancreatic cancer?


Research in pancreatic cancer treatment is ongoing, and there have been some advancements and emerging treatments. These include:

  • Immunotherapy: This approach uses drugs to help the immune system recognise and attack cancer cells.
  • Targeted therapies: New targeted therapies are being developed to specifically target genetic mutations or abnormal proteins in pancreatic cancer cells.
  • Personalised medicine: Advances in genetic testing allow for a more personalised approach to treatment, identifying specific genetic alterations in a patient's tumour and tailoring treatment accordingly.
  • Clinical trials: Participation in clinical trials provides access to innovative treatments that are being tested and that can potentially improve outcomes.


It is important to consult with healthcare professionals and specialists who can provide the most up-to-date information on advancements in pancreatic cancer treatment.



Mr Charles Imber is a leading consultant general surgeon with over 20 years’ experience.


If you require expert treatment and management for pancreatic cancer, do not hesitate to reach out to Mr Imber via his Top Doctors profile today.

By Mr Charles Imber

Mr Charles Imber is a prominent London-based consultant general surgeon with more than 20 years of experience working as a medical professional. He specialises in emergency surgery, gallbladder surgery, laparoscopic surgery, liver surgery, pancreas surgery, and hernias. He currently practises at the Cleveland Clinic London Hospital

After completing his medical studies at Manchester University and Cambridge University respectively, he began specialising in liver transplants, hepatobiliary surgery, and pancreatic surgery, working at hospitals in London, Cambridge, and Birmingham, before officially becoming a consultant surgeon in 2006. Impressively, Mr Imber was, in 2012, awarded a HCA Travelling Fellowship, after having previously been awarded numerous other notable awards, including the Presentation Travel Award from the International Liver Transplant Society, which he was awarded with in 2006. 

His other clinical interests include hernia surgery and gallbladder surgery. Always aiming to maximise patient care, he employs the use of the best technologies available, and is a pioneer of innovative mesh techniques for hernia repair. He is also an expert in both simple operations and more complicated cases, and has written extensively for peer-reviewed journals.

View Profile

Overall assessment of their patients

  • Related procedures
  • Mouth cancer
    Prostate cancer
    Human papillomavirus (HPV)
    Human papillomavirus vaccine (HPV)
    Breast cancer
    Brain tumour
    Testicular cancer
    Thyroid cancer
    Adrenal glands cancer
    Doppler Ultrasound
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.